Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions
John Pfail, Andrew Katims, Parissa Alerasool, John P. Sfakianos
Topics & Concepts
MedicineCystectomyBladder cancerImmunotherapyOncologyInternal medicineClinical trialDiseaseDurvalumabIntensive care medicineRandomized controlled trialPopulationCancerPembrolizumabEnvironmental healthBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersImmune responses and vaccinations